Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

USFDA completes audit at Dr. Reddy’s CPS facility in Telangana

Date: 21-09-2017

US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy’s Laboratories’ Custom Pharmaceutical Services (CPS) facility, Technology Development Centre (TDC-1) at Miyapur, Hyderabad, Telangana with Zero observations on September 21, 2017.

Earlier, the USFDA had completed the inspection at Dr. Reddy’s Laboratories’ API Mirfield Plant, United Kingdom on September 15, 2017.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.